Literature DB >> 25146229

Massive Atenolol, Lisinopril, and Chlorthalidone Overdose Treated with Endoscopic Decontamination, Hemodialysis, Impella Percutaneous Left Ventricular Assist Device, and ECMO.

C William Heise1, David Beutler, Adam Bosak, Geoffrey Orme, Akil Loli, Kimberlie Graeme.   

Abstract

BACKGROUND: Overdose of cardiovascular medications is increasingly associated with morbidity and mortality. We present a case of substantial atenolol, chlorthalidone, and lisinopril overdose treated by multiple modalities with an excellent outcome.
CONCLUSION: Aggressive medical intervention did not provide sufficient hemodynamic stability in this patient with refractory cardiogenic and distributive shock. Impella® percutaneous left ventricular assist device and extracorporeal membrane oxygenation provided support while the effects of the overdose subsided. We present concentrations demonstrating removal of atenolol with continuous venovenous hemodiafiltration. This is the first report of esophagogastroduo denoscopy decontamination of this overdose with a large pill fragment burden.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25146229      PMCID: PMC4371031          DOI: 10.1007/s13181-014-0419-y

Source DB:  PubMed          Journal:  J Med Toxicol        ISSN: 1556-9039


  24 in total

Review 1.  Chlorthalidone: the forgotten diuretic.

Authors:  David S Kountz; Andrew Goldman; John Mikhail; Mayer Ezer
Journal:  Postgrad Med       Date:  2012-01       Impact factor: 3.840

2.  A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II study.

Authors:  William W O'Neill; Neal S Kleiman; Jeffrey Moses; Jose P S Henriques; Simon Dixon; Joseph Massaro; Igor Palacios; Brijeshwar Maini; Suresh Mulukutla; Vladimír Dzavík; Jeffrey Popma; Pamela S Douglas; Magnus Ohman
Journal:  Circulation       Date:  2012-08-30       Impact factor: 29.690

3.  Different applications for left ventricular mechanical support with the Impella Recover 100 microaxial blood pump.

Authors:  Andrea Garatti; Tiziano Colombo; Claudio Russo; Marco Lanfranconi; Filippo Milazzo; Emanuele Catena; Guiseppe Bruschi; Maria Frigerio; Ettore Vitali
Journal:  J Heart Lung Transplant       Date:  2005-04       Impact factor: 10.247

4.  Severe hemolysis associated with use of the Impella LP 2.5 mechanical assist device.

Authors:  Matthew Sibbald; Vladimír Džavík
Journal:  Catheter Cardiovasc Interv       Date:  2012-04-17       Impact factor: 2.692

5.  Bezoar formation requiring endoscopic removal after intentional overdose of extended-release nifedipine.

Authors:  Christopher D Wells; Todd C Luckritz; Mohamed Y Rady; Jessica M Zornik; Jonathan A Leighton; Bhavesh M Patel
Journal:  Pharmacotherapy       Date:  2006-12       Impact factor: 4.705

6.  Abdominal aortic aneurysm surgery with mechanical support using the Impella microaxial blood pump.

Authors:  Fadi Farhat; Thomas Sassard; Yassin Attof; Olivier Jegaden
Journal:  Interact Cardiovasc Thorac Surg       Date:  2008-02-14

7.  A prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (The PROTECT I Trial): initial U.S. experience.

Authors:  Simon R Dixon; José P S Henriques; Laura Mauri; Krischan Sjauw; Andrew Civitello; Biswajit Kar; Pranav Loyalka; Frederic S Resnic; Paul Teirstein; Raj Makkar; Igor F Palacios; Michael Collins; Jeffrey Moses; Karim Benali; William W O'Neill
Journal:  JACC Cardiovasc Interv       Date:  2009-02       Impact factor: 11.195

8.  A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction.

Authors:  Melchior Seyfarth; Dirk Sibbing; Iris Bauer; Georg Fröhlich; Lorenz Bott-Flügel; Robert Byrne; Josef Dirschinger; Adnan Kastrati; Albert Schömig
Journal:  J Am Coll Cardiol       Date:  2008-11-04       Impact factor: 24.094

9.  Use of the Impella microaxial blood pump for ablation of hemodynamically unstable ventricular tachycardia.

Authors:  Hussam Abuissa; John Roshan; Bernard Lim; Samuel J Asirvatham
Journal:  J Cardiovasc Electrophysiol       Date:  2009-12-21

10.  Comparison of Impella and intra-aortic balloon pump in high-risk percutaneous coronary intervention: vascular complications and incidence of bleeding.

Authors:  Konstantinos Dean Boudoulas; Andrew Pederzolli; Uksha Saini; Richard J Gumina; Ernest L Mazzaferri; Michael Davis; Charles A Bush; Quinn Capers; Raymond Magorien; Vincent J Pompili
Journal:  Acute Card Care       Date:  2012-12
View more
  2 in total

1.  Use of a Porcine Model to Evaluate the Risks and Benefits of Vasopressors in Propranolol Poisoning.

Authors:  Jon B Cole; Justin N Corcoran; Kristin M Engebretsen; Samuel J Stellpflug
Journal:  J Med Toxicol       Date:  2020-01-24

2.  Extracorporeal treatment for poisoning to beta-adrenergic antagonists: systematic review and recommendations from the EXTRIP workgroup.

Authors:  Josée Bouchard; Greene Shepherd; Robert S Hoffman; Sophie Gosselin; Darren M Roberts; Yi Li; Thomas D Nolin; Valéry Lavergne; Marc Ghannoum
Journal:  Crit Care       Date:  2021-06-10       Impact factor: 9.097

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.